DOI:

Introduction and thoughts on the second issue of EuroIntervention

Patrick W.Serruys, Editor-in-Chief
Volume 1 Number 2
Aug 20, 2005
Volume 1 Number 2
View full issue

Key metrics

Suggested by Cory

Trial Design

10.4244/EIJ-D-25-00486 • Sep 30, 2025
Mechanical circulatory support in high-risk elective PCI: rationale and design of the PROTECT IV trial
Mangner N et al
free

Snapshot

Sep 15, 2025
A State-of-the-Art on antithrombotic therapy in complex PCI; optimal minimal stent areas after left main crossover stenting; VARC-HBR criteria validation for TAVI; the balloon-expandable DurAVR transcatheter heart valve; valve-in-valve TAVI and redo-TAVI; and more...
free

Editorial

10.4244/EIJ-E-25-00022 • Sep 15, 2025
An ongoing quest to discern the optimal antithrombotic therapy after TAVI
Hayashida K and Iwata J
free

Research Correspondence

10.4244/EIJ-D-25-00255 • Sep 15, 2025
Redo-TAVI with the ACURATE platform for failure of short-frame transcatheter heart valves
Tarantini G et al

Editorial

10.4244/EIJ-E-25-00038 • Sep 15, 2025
Evolving cutoff values for optimising left main stenting with intravascular imaging
de la Torre Hernandez J
free

Original Research

10.4244/EIJ-D-24-01066 • Sep 15, 2025
VARC-HBR criteria validation in TAVI patients on oral anticoagulation
Overduin D et al

Translational research

10.4244/EIJ-D-24-01000 • Sep 15, 2025
DurAVR – a novel biomimetic balloon-expandable transcatheter valve for TAVI, valve-in-valve TAVI and redo-TAVI
Meier D et al
open access

Original Research

10.4244/EIJ-D-25-00122 • Sep 15, 2025
Optimal minimal stent area after crossover stenting in patients with unprotected left main coronary artery disease
Kim JH et al

Flashlight

10.4244/EIJ-D-25-00121 • Sep 15, 2025
Calcium mapping by 3DStent technology
Amabile N and Benamer H

Viewpoint

10.4244/EIJ-D-25-00323 • Sep 15, 2025
Early interruption of dual antiplatelet therapy after an acute myocardial ischaemic syndrome: but what then?
Stefanini G et al
free
Trending articles
122.35

Expert consensus

10.4244/EIJ-D-22-00723 • Mar 20, 2023
Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
Barbato E et al
free
96.55

State-of-the-Art

10.4244/EIJ-D-24-00066 • Apr 21, 2025
Management of complications after valvular interventions
Bansal A et al
free
67.15

State-of-the-Art

10.4244/EIJ-D-24-00992 • Sep 15, 2025
Antithrombotic therapy in complex percutaneous coronary intervention
Castiello D et al
free
64.25

Original Research

10.4244/EIJ-D-24-00055 • Sep 16, 2024
Vascular response following implantation of the third-generation drug-eluting resorbable coronary magnesium scaffold: an intravascular imaging analysis of the BIOMAG-I first-in-human study
Seguchi M et al
free
56.1

Original Research

10.4244/EIJ-D-25-00331 • May 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
56.1

Original Research

10.4244/EIJ-D-25-00331 • Jul 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
46.85

EXPERT REVIEW

10.4244/EIJ-D-18-00194 • Jul 20, 2018
Intravascular ultrasound in the evaluation and treatment of left main coronary artery disease: a consensus statement from the European Bifurcation Club
Mintz GS et al
free
43.65

CLINICAL RESEARCH

10.4244/EIJ-D-17-00634 • Nov 20, 2017
Clopidogrel or ticagrelor in acute coronary syndrome patients treated with newer-generation drug-eluting stents: CHANGE DAPT
Zocca P et al
free
38.4

Original Research

10.4244/EIJ-D-25-00122 • Sep 15, 2025
Optimal minimal stent area after crossover stenting in patients with unprotected left main coronary artery disease
Kim JH et al
35.45

State-of-the-Art

10.4244/EIJ-D-23-00448 • Jan 15, 2024
Coronary spasm and vasomotor dysfunction as a cause of MINOCA
Yaker ZS et al
free
23.95

Original Research

10.4244/EIJ-D-25-00826 • Aug 30, 2025
Effect of beta blocker withholding or withdrawal after myocardial infarction without reduced ejection fraction on ischaemic events: a post hoc analysis from the REBOOT trial
Rossello X et al
open access
X
PCR
Readers
Current issue
Archives
Subscriptions
Authors
Submit your paper
Instructions
Services
Advertise
Reprints / ePrints
Rights and permissions
Textbooks
The PCR Textbook
The history of angioplasty
Percutaneous cardiac interventions
About the journal
Editorial team
Disclaimer
Legal notice
Privacy policy
Cookie Management
Follow us
Facebook
X
Instagram
LinkedIn
YouTube
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved